A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Conditions

• Hepatitis B

Interventions

• COMBINATION_PRODUCT: GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
• BIOLOGICAL: GSK's HBsAg candidate vaccine adjuvanted with GSK's AS03 adjuvant system
• BIOLOGICAL: GSK's Hepatitis B vaccine adjuvanted with GSK's AS04 adjuvant system
• BIOLOGICAL: GSK's HBsAg (20 μg) vaccine adjuvanted with GSK's AS37B adjuvant system (50 μg)
• BIOLOGICAL: GSK's HBsAg (20 μg) vaccine adjuvanted with GSK's AS37A adjuvant system (100 μg)

Sponsor

GlaxoSmithKline